Skip to content

Drug interactions

Cenobamate + Ixazomib

Severity: Moderate

Cenobamate and Ixazomib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Cenobamate induces CYP3A4 and may reduce ixazomib exposure. Strong CYP3A inducers markedly lower ixazomib exposure, and cenobamate is a moderate inducer, so loss of efficacy is possible.

What this interaction means in plain words

Cenobamate and Ixazomib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Cenobamate belongs to Central Nervous System; Ixazomib belongs to Oncology.

Evidence level: Low

Why it happens

Cenobamate induces CYP3A4, increasing ixazomib clearance.

What to do

Consider an alternative antiseizure drug without enzyme-inducing activity. If the combination is used, monitor myeloma response and do not increase the ixazomib dose empirically.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Cenobamate and Ixazomib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Cenobamate with Ixazomib?

MediHelp rates the interaction as moderate. Cenobamate and Ixazomib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Cenobamate induces CYP3A4 and may reduce ixazomib exposure. Strong CYP3A inducers markedly lower ixazomib exposure, and cenobamate is a moderate inducer, so loss of efficacy is possible.

How serious is the interaction between Cenobamate and Ixazomib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Consider an alternative antiseizure drug without enzyme-inducing activity. If the combination is used, monitor myeloma response and do not increase the ixazomib dose empirically.

What other medicines interact with Ixazomib?

MediHelp also lists interactions of Ixazomib with, for example, Apalutamide, Carbamazepine, Dabrafenib. The full list is on the Ixazomib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in